Dipna Pharmachem Ltd — Important, 28-08-2025: Company Update

DIPNA PHARMACHEM LIMITED has clarified its approach to appointing a Monitoring Agency for its proposed Preferential Issue of Equity Shares. While an agency is typically mandatory for issues exceeding 100 Crore, the company's current proposed issue size is less than this threshold, meaning an appointment is not currently required. However, the company has committed to appointing a Monitoring Agency if the final issue size eventually exceeds 90 Crore. This provides clarity on their compliance and oversight for the upcoming share issue.